Pharma & Healthcare
Global Veterinary Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 07, 25
- ID: 168274
- Pages: 115
- Figures: 115
- Views: 43
The global Veterinary Vaccine market size was US$ 12390 million in 2024 and is forecast to a readjusted size of US$ 19690 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Factors influencing growth in demand for farm vaccines include:
• human population growth and increasing standards of living, particularly in many emerging markets;
• increasing demand for improved nutrition, particularly animal protein;
• natural resource constraints, such as scarcity of arable land, fresh water and increased competition for cultivated land, resulting in fewer resources that will be available to meet this increased demand for animal protein;
• increasing urbanization and increased focus on food safety and food security. Rising concerns over food security and increasing animal husbandry are boosting the demand for animal vaccines for the livestock population. Increasing demand for animal products has led to growth in livestock production globally.
The primary companion animal species are dogs, cats and horses. Factors influencing growth in demand for companion animal vaccines include:
• economic development and related increases in disposable income, particularly in many emerging markets;
• increasing pet ownership
• companion animals living longer, increasing medical treatment of companion animals and advances in companion animal medicines and vaccines.
North Americas is the largest consumption place, with a consumption market share nearly 36% in 2023. Following North Americas, APAC is the second largest consumption place with the consumption market share of 30%.
Global key Veterinary Vaccine players cover Merck, Boehringer Ingelheim, Zoetis, Elanco, Ceva, CAHIC, Jinyu Bio-Technology, HVRI, Ringpu Biology, Virbac, etc. In terms of revenue, the global five largest companies occupied for a share nearly 75.64% in 2023.
The global Veterinary Vaccine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
Medion
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
RVSRI
By Type: (Dominant Segment vs High-Margin Innovation)
Live Attenuated Vaccines
Inactivated Vaccines
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Farm Animal
Companion Animal
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Merck in Europe)
- Emerging Product Trends: Live Attenuated Vaccines adoption vs. Inactivated Vaccines premiumization
- Demand-Side Dynamics: Farm Animal growth in China vs. Companion Animal potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Veterinary Vaccine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Inactivated Vaccines in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Companion Animal in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Live Attenuated Vaccines dominance in Europe vs. Inactivated Vaccines demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Factors influencing growth in demand for farm vaccines include:
• human population growth and increasing standards of living, particularly in many emerging markets;
• increasing demand for improved nutrition, particularly animal protein;
• natural resource constraints, such as scarcity of arable land, fresh water and increased competition for cultivated land, resulting in fewer resources that will be available to meet this increased demand for animal protein;
• increasing urbanization and increased focus on food safety and food security. Rising concerns over food security and increasing animal husbandry are boosting the demand for animal vaccines for the livestock population. Increasing demand for animal products has led to growth in livestock production globally.
The primary companion animal species are dogs, cats and horses. Factors influencing growth in demand for companion animal vaccines include:
• economic development and related increases in disposable income, particularly in many emerging markets;
• increasing pet ownership
• companion animals living longer, increasing medical treatment of companion animals and advances in companion animal medicines and vaccines.
North Americas is the largest consumption place, with a consumption market share nearly 36% in 2023. Following North Americas, APAC is the second largest consumption place with the consumption market share of 30%.
Global key Veterinary Vaccine players cover Merck, Boehringer Ingelheim, Zoetis, Elanco, Ceva, CAHIC, Jinyu Bio-Technology, HVRI, Ringpu Biology, Virbac, etc. In terms of revenue, the global five largest companies occupied for a share nearly 75.64% in 2023.
The global Veterinary Vaccine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
Medion
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
RVSRI
By Type: (Dominant Segment vs High-Margin Innovation)
Live Attenuated Vaccines
Inactivated Vaccines
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Farm Animal
Companion Animal
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Merck in Europe)
- Emerging Product Trends: Live Attenuated Vaccines adoption vs. Inactivated Vaccines premiumization
- Demand-Side Dynamics: Farm Animal growth in China vs. Companion Animal potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Veterinary Vaccine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Inactivated Vaccines in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Companion Animal in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Live Attenuated Vaccines dominance in Europe vs. Inactivated Vaccines demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Veterinary Vaccine Product Scope
1.2 Veterinary Vaccine by Type
1.2.1 Global Veterinary Vaccine Sales by Type (2020 & 2024 & 2031)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Other
1.3 Veterinary Vaccine by Application
1.3.1 Global Veterinary Vaccine Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Farm Animal
1.3.3 Companion Animal
1.4 Global Veterinary Vaccine Market Estimates and Forecasts (2020-2031)
1.4.1 Global Veterinary Vaccine Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Veterinary Vaccine Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Veterinary Vaccine Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Veterinary Vaccine Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Veterinary Vaccine Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Veterinary Vaccine Sales Market Share by Region (2020-2025)
2.2.2 Global Veterinary Vaccine Revenue Market Share by Region (2020-2025)
2.3 Global Veterinary Vaccine Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Veterinary Vaccine Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Veterinary Vaccine Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Veterinary Vaccine Market Size and Prospective (2020-2031)
2.4.2 Europe Veterinary Vaccine Market Size and Prospective (2020-2031)
2.4.3 China Veterinary Vaccine Market Size and Prospective (2020-2031)
2.4.4 Japan Veterinary Vaccine Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Veterinary Vaccine Historic Market Review by Type (2020-2025)
3.1.1 Global Veterinary Vaccine Sales by Type (2020-2025)
3.1.2 Global Veterinary Vaccine Revenue by Type (2020-2025)
3.1.3 Global Veterinary Vaccine Price by Type (2020-2025)
3.2 Global Veterinary Vaccine Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Veterinary Vaccine Sales Forecast by Type (2026-2031)
3.2.2 Global Veterinary Vaccine Revenue Forecast by Type (2026-2031)
3.2.3 Global Veterinary Vaccine Price Forecast by Type (2026-2031)
3.3 Different Types Veterinary Vaccine Representative Players
4 Global Market Size by Application
4.1 Global Veterinary Vaccine Historic Market Review by Application (2020-2025)
4.1.1 Global Veterinary Vaccine Sales by Application (2020-2025)
4.1.2 Global Veterinary Vaccine Revenue by Application (2020-2025)
4.1.3 Global Veterinary Vaccine Price by Application (2020-2025)
4.2 Global Veterinary Vaccine Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Veterinary Vaccine Sales Forecast by Application (2026-2031)
4.2.2 Global Veterinary Vaccine Revenue Forecast by Application (2026-2031)
4.2.3 Global Veterinary Vaccine Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Veterinary Vaccine Application
5 Competition Landscape by Players
5.1 Global Veterinary Vaccine Sales by Players (2020-2025)
5.2 Global Top Veterinary Vaccine Players by Revenue (2020-2025)
5.3 Global Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2024)
5.4 Global Veterinary Vaccine Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Veterinary Vaccine, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Veterinary Vaccine, Product Type & Application
5.7 Global Key Manufacturers of Veterinary Vaccine, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Veterinary Vaccine Sales by Company
6.1.1.1 North America Veterinary Vaccine Sales by Company (2020-2025)
6.1.1.2 North America Veterinary Vaccine Revenue by Company (2020-2025)
6.1.2 North America Veterinary Vaccine Sales Breakdown by Type (2020-2025)
6.1.3 North America Veterinary Vaccine Sales Breakdown by Application (2020-2025)
6.1.4 North America Veterinary Vaccine Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Veterinary Vaccine Sales by Company
6.2.1.1 Europe Veterinary Vaccine Sales by Company (2020-2025)
6.2.1.2 Europe Veterinary Vaccine Revenue by Company (2020-2025)
6.2.2 Europe Veterinary Vaccine Sales Breakdown by Type (2020-2025)
6.2.3 Europe Veterinary Vaccine Sales Breakdown by Application (2020-2025)
6.2.4 Europe Veterinary Vaccine Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Veterinary Vaccine Sales by Company
6.3.1.1 China Veterinary Vaccine Sales by Company (2020-2025)
6.3.1.2 China Veterinary Vaccine Revenue by Company (2020-2025)
6.3.2 China Veterinary Vaccine Sales Breakdown by Type (2020-2025)
6.3.3 China Veterinary Vaccine Sales Breakdown by Application (2020-2025)
6.3.4 China Veterinary Vaccine Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Veterinary Vaccine Sales by Company
6.4.1.1 Japan Veterinary Vaccine Sales by Company (2020-2025)
6.4.1.2 Japan Veterinary Vaccine Revenue by Company (2020-2025)
6.4.2 Japan Veterinary Vaccine Sales Breakdown by Type (2020-2025)
6.4.3 Japan Veterinary Vaccine Sales Breakdown by Application (2020-2025)
6.4.4 Japan Veterinary Vaccine Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Business Overview
7.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Merck Veterinary Vaccine Products Offered
7.1.5 Merck Recent Development
7.2 Zoetis
7.2.1 Zoetis Company Information
7.2.2 Zoetis Business Overview
7.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Zoetis Veterinary Vaccine Products Offered
7.2.5 Zoetis Recent Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Information
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Boehringer Ingelheim Veterinary Vaccine Products Offered
7.3.5 Boehringer Ingelheim Recent Development
7.4 Ceva
7.4.1 Ceva Company Information
7.4.2 Ceva Business Overview
7.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Ceva Veterinary Vaccine Products Offered
7.4.5 Ceva Recent Development
7.5 CAHIC
7.5.1 CAHIC Company Information
7.5.2 CAHIC Business Overview
7.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.5.4 CAHIC Veterinary Vaccine Products Offered
7.5.5 CAHIC Recent Development
7.6 HVRI
7.6.1 HVRI Company Information
7.6.2 HVRI Business Overview
7.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.6.4 HVRI Veterinary Vaccine Products Offered
7.6.5 HVRI Recent Development
7.7 Ringpu Biology
7.7.1 Ringpu Biology Company Information
7.7.2 Ringpu Biology Business Overview
7.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Ringpu Biology Veterinary Vaccine Products Offered
7.7.5 Ringpu Biology Recent Development
7.8 Yebio
7.8.1 Yebio Company Information
7.8.2 Yebio Business Overview
7.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Yebio Veterinary Vaccine Products Offered
7.8.5 Yebio Recent Development
7.9 DHN
7.9.1 DHN Company Information
7.9.2 DHN Business Overview
7.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.9.4 DHN Veterinary Vaccine Products Offered
7.9.5 DHN Recent Development
7.10 WINSUN
7.10.1 WINSUN Company Information
7.10.2 WINSUN Business Overview
7.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.10.4 WINSUN Veterinary Vaccine Products Offered
7.10.5 WINSUN Recent Development
7.11 Elanco
7.11.1 Elanco Company Information
7.11.2 Elanco Business Overview
7.11.3 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Elanco Veterinary Vaccine Products Offered
7.11.5 Elanco Recent Development
7.12 Virbac
7.12.1 Virbac Company Information
7.12.2 Virbac Business Overview
7.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Virbac Veterinary Vaccine Products Offered
7.12.5 Virbac Recent Development
7.13 Jinyu Bio-Technology
7.13.1 Jinyu Bio-Technology Company Information
7.13.2 Jinyu Bio-Technology Business Overview
7.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Jinyu Bio-Technology Veterinary Vaccine Products Offered
7.13.5 Jinyu Bio-Technology Recent Development
7.14 Medion
7.14.1 Medion Company Information
7.14.2 Medion Business Overview
7.14.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Medion Veterinary Vaccine Products Offered
7.14.5 Medion Recent Development
7.15 CAVAC
7.15.1 CAVAC Company Information
7.15.2 CAVAC Business Overview
7.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.15.4 CAVAC Veterinary Vaccine Products Offered
7.15.5 CAVAC Recent Development
7.16 Kyoto Biken Laboratories
7.16.1 Kyoto Biken Laboratories Company Information
7.16.2 Kyoto Biken Laboratories Business Overview
7.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Kyoto Biken Laboratories Veterinary Vaccine Products Offered
7.16.5 Kyoto Biken Laboratories Recent Development
7.17 FATRO
7.17.1 FATRO Company Information
7.17.2 FATRO Business Overview
7.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.17.4 FATRO Veterinary Vaccine Products Offered
7.17.5 FATRO Recent Development
7.18 Vaksindo
7.18.1 Vaksindo Company Information
7.18.2 Vaksindo Business Overview
7.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Vaksindo Veterinary Vaccine Products Offered
7.18.5 Vaksindo Recent Development
7.19 Bio-Labs
7.19.1 Bio-Labs Company Information
7.19.2 Bio-Labs Business Overview
7.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.19.4 Bio-Labs Veterinary Vaccine Products Offered
7.19.5 Bio-Labs Recent Development
7.20 Avimex Animal Health
7.20.1 Avimex Animal Health Company Information
7.20.2 Avimex Animal Health Business Overview
7.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.20.4 Avimex Animal Health Veterinary Vaccine Products Offered
7.20.5 Avimex Animal Health Recent Development
7.21 MEVAC
7.21.1 MEVAC Company Information
7.21.2 MEVAC Business Overview
7.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.21.4 MEVAC Veterinary Vaccine Products Offered
7.21.5 MEVAC Recent Development
7.22 Biovac
7.22.1 Biovac Company Information
7.22.2 Biovac Business Overview
7.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.22.4 Biovac Veterinary Vaccine Products Offered
7.22.5 Biovac Recent Development
7.23 Atafen
7.23.1 Atafen Company Information
7.23.2 Atafen Business Overview
7.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.23.4 Atafen Veterinary Vaccine Products Offered
7.23.5 Atafen Recent Development
7.24 Dyntec
7.24.1 Dyntec Company Information
7.24.2 Dyntec Business Overview
7.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.24.4 Dyntec Veterinary Vaccine Products Offered
7.24.5 Dyntec Recent Development
7.25 RVSRI
7.25.1 RVSRI Company Information
7.25.2 RVSRI Business Overview
7.25.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.25.4 RVSRI Veterinary Vaccine Products Offered
7.25.5 RVSRI Recent Development
8 Veterinary Vaccine Manufacturing Cost Analysis
8.1 Veterinary Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Veterinary Vaccine
8.4 Veterinary Vaccine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Veterinary Vaccine Distributors List
9.3 Veterinary Vaccine Customers
10 Veterinary Vaccine Market Dynamics
10.1 Veterinary Vaccine Industry Trends
10.2 Veterinary Vaccine Market Drivers
10.3 Veterinary Vaccine Market Challenges
10.4 Veterinary Vaccine Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Veterinary Vaccine Product Scope
1.2 Veterinary Vaccine by Type
1.2.1 Global Veterinary Vaccine Sales by Type (2020 & 2024 & 2031)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Other
1.3 Veterinary Vaccine by Application
1.3.1 Global Veterinary Vaccine Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Farm Animal
1.3.3 Companion Animal
1.4 Global Veterinary Vaccine Market Estimates and Forecasts (2020-2031)
1.4.1 Global Veterinary Vaccine Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Veterinary Vaccine Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Veterinary Vaccine Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Veterinary Vaccine Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Veterinary Vaccine Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Veterinary Vaccine Sales Market Share by Region (2020-2025)
2.2.2 Global Veterinary Vaccine Revenue Market Share by Region (2020-2025)
2.3 Global Veterinary Vaccine Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Veterinary Vaccine Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Veterinary Vaccine Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Veterinary Vaccine Market Size and Prospective (2020-2031)
2.4.2 Europe Veterinary Vaccine Market Size and Prospective (2020-2031)
2.4.3 China Veterinary Vaccine Market Size and Prospective (2020-2031)
2.4.4 Japan Veterinary Vaccine Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Veterinary Vaccine Historic Market Review by Type (2020-2025)
3.1.1 Global Veterinary Vaccine Sales by Type (2020-2025)
3.1.2 Global Veterinary Vaccine Revenue by Type (2020-2025)
3.1.3 Global Veterinary Vaccine Price by Type (2020-2025)
3.2 Global Veterinary Vaccine Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Veterinary Vaccine Sales Forecast by Type (2026-2031)
3.2.2 Global Veterinary Vaccine Revenue Forecast by Type (2026-2031)
3.2.3 Global Veterinary Vaccine Price Forecast by Type (2026-2031)
3.3 Different Types Veterinary Vaccine Representative Players
4 Global Market Size by Application
4.1 Global Veterinary Vaccine Historic Market Review by Application (2020-2025)
4.1.1 Global Veterinary Vaccine Sales by Application (2020-2025)
4.1.2 Global Veterinary Vaccine Revenue by Application (2020-2025)
4.1.3 Global Veterinary Vaccine Price by Application (2020-2025)
4.2 Global Veterinary Vaccine Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Veterinary Vaccine Sales Forecast by Application (2026-2031)
4.2.2 Global Veterinary Vaccine Revenue Forecast by Application (2026-2031)
4.2.3 Global Veterinary Vaccine Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Veterinary Vaccine Application
5 Competition Landscape by Players
5.1 Global Veterinary Vaccine Sales by Players (2020-2025)
5.2 Global Top Veterinary Vaccine Players by Revenue (2020-2025)
5.3 Global Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2024)
5.4 Global Veterinary Vaccine Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Veterinary Vaccine, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Veterinary Vaccine, Product Type & Application
5.7 Global Key Manufacturers of Veterinary Vaccine, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Veterinary Vaccine Sales by Company
6.1.1.1 North America Veterinary Vaccine Sales by Company (2020-2025)
6.1.1.2 North America Veterinary Vaccine Revenue by Company (2020-2025)
6.1.2 North America Veterinary Vaccine Sales Breakdown by Type (2020-2025)
6.1.3 North America Veterinary Vaccine Sales Breakdown by Application (2020-2025)
6.1.4 North America Veterinary Vaccine Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Veterinary Vaccine Sales by Company
6.2.1.1 Europe Veterinary Vaccine Sales by Company (2020-2025)
6.2.1.2 Europe Veterinary Vaccine Revenue by Company (2020-2025)
6.2.2 Europe Veterinary Vaccine Sales Breakdown by Type (2020-2025)
6.2.3 Europe Veterinary Vaccine Sales Breakdown by Application (2020-2025)
6.2.4 Europe Veterinary Vaccine Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Veterinary Vaccine Sales by Company
6.3.1.1 China Veterinary Vaccine Sales by Company (2020-2025)
6.3.1.2 China Veterinary Vaccine Revenue by Company (2020-2025)
6.3.2 China Veterinary Vaccine Sales Breakdown by Type (2020-2025)
6.3.3 China Veterinary Vaccine Sales Breakdown by Application (2020-2025)
6.3.4 China Veterinary Vaccine Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Veterinary Vaccine Sales by Company
6.4.1.1 Japan Veterinary Vaccine Sales by Company (2020-2025)
6.4.1.2 Japan Veterinary Vaccine Revenue by Company (2020-2025)
6.4.2 Japan Veterinary Vaccine Sales Breakdown by Type (2020-2025)
6.4.3 Japan Veterinary Vaccine Sales Breakdown by Application (2020-2025)
6.4.4 Japan Veterinary Vaccine Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Business Overview
7.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Merck Veterinary Vaccine Products Offered
7.1.5 Merck Recent Development
7.2 Zoetis
7.2.1 Zoetis Company Information
7.2.2 Zoetis Business Overview
7.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Zoetis Veterinary Vaccine Products Offered
7.2.5 Zoetis Recent Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Information
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Boehringer Ingelheim Veterinary Vaccine Products Offered
7.3.5 Boehringer Ingelheim Recent Development
7.4 Ceva
7.4.1 Ceva Company Information
7.4.2 Ceva Business Overview
7.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Ceva Veterinary Vaccine Products Offered
7.4.5 Ceva Recent Development
7.5 CAHIC
7.5.1 CAHIC Company Information
7.5.2 CAHIC Business Overview
7.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.5.4 CAHIC Veterinary Vaccine Products Offered
7.5.5 CAHIC Recent Development
7.6 HVRI
7.6.1 HVRI Company Information
7.6.2 HVRI Business Overview
7.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.6.4 HVRI Veterinary Vaccine Products Offered
7.6.5 HVRI Recent Development
7.7 Ringpu Biology
7.7.1 Ringpu Biology Company Information
7.7.2 Ringpu Biology Business Overview
7.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Ringpu Biology Veterinary Vaccine Products Offered
7.7.5 Ringpu Biology Recent Development
7.8 Yebio
7.8.1 Yebio Company Information
7.8.2 Yebio Business Overview
7.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Yebio Veterinary Vaccine Products Offered
7.8.5 Yebio Recent Development
7.9 DHN
7.9.1 DHN Company Information
7.9.2 DHN Business Overview
7.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.9.4 DHN Veterinary Vaccine Products Offered
7.9.5 DHN Recent Development
7.10 WINSUN
7.10.1 WINSUN Company Information
7.10.2 WINSUN Business Overview
7.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.10.4 WINSUN Veterinary Vaccine Products Offered
7.10.5 WINSUN Recent Development
7.11 Elanco
7.11.1 Elanco Company Information
7.11.2 Elanco Business Overview
7.11.3 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Elanco Veterinary Vaccine Products Offered
7.11.5 Elanco Recent Development
7.12 Virbac
7.12.1 Virbac Company Information
7.12.2 Virbac Business Overview
7.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Virbac Veterinary Vaccine Products Offered
7.12.5 Virbac Recent Development
7.13 Jinyu Bio-Technology
7.13.1 Jinyu Bio-Technology Company Information
7.13.2 Jinyu Bio-Technology Business Overview
7.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Jinyu Bio-Technology Veterinary Vaccine Products Offered
7.13.5 Jinyu Bio-Technology Recent Development
7.14 Medion
7.14.1 Medion Company Information
7.14.2 Medion Business Overview
7.14.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Medion Veterinary Vaccine Products Offered
7.14.5 Medion Recent Development
7.15 CAVAC
7.15.1 CAVAC Company Information
7.15.2 CAVAC Business Overview
7.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.15.4 CAVAC Veterinary Vaccine Products Offered
7.15.5 CAVAC Recent Development
7.16 Kyoto Biken Laboratories
7.16.1 Kyoto Biken Laboratories Company Information
7.16.2 Kyoto Biken Laboratories Business Overview
7.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Kyoto Biken Laboratories Veterinary Vaccine Products Offered
7.16.5 Kyoto Biken Laboratories Recent Development
7.17 FATRO
7.17.1 FATRO Company Information
7.17.2 FATRO Business Overview
7.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.17.4 FATRO Veterinary Vaccine Products Offered
7.17.5 FATRO Recent Development
7.18 Vaksindo
7.18.1 Vaksindo Company Information
7.18.2 Vaksindo Business Overview
7.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Vaksindo Veterinary Vaccine Products Offered
7.18.5 Vaksindo Recent Development
7.19 Bio-Labs
7.19.1 Bio-Labs Company Information
7.19.2 Bio-Labs Business Overview
7.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.19.4 Bio-Labs Veterinary Vaccine Products Offered
7.19.5 Bio-Labs Recent Development
7.20 Avimex Animal Health
7.20.1 Avimex Animal Health Company Information
7.20.2 Avimex Animal Health Business Overview
7.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.20.4 Avimex Animal Health Veterinary Vaccine Products Offered
7.20.5 Avimex Animal Health Recent Development
7.21 MEVAC
7.21.1 MEVAC Company Information
7.21.2 MEVAC Business Overview
7.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.21.4 MEVAC Veterinary Vaccine Products Offered
7.21.5 MEVAC Recent Development
7.22 Biovac
7.22.1 Biovac Company Information
7.22.2 Biovac Business Overview
7.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.22.4 Biovac Veterinary Vaccine Products Offered
7.22.5 Biovac Recent Development
7.23 Atafen
7.23.1 Atafen Company Information
7.23.2 Atafen Business Overview
7.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.23.4 Atafen Veterinary Vaccine Products Offered
7.23.5 Atafen Recent Development
7.24 Dyntec
7.24.1 Dyntec Company Information
7.24.2 Dyntec Business Overview
7.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.24.4 Dyntec Veterinary Vaccine Products Offered
7.24.5 Dyntec Recent Development
7.25 RVSRI
7.25.1 RVSRI Company Information
7.25.2 RVSRI Business Overview
7.25.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.25.4 RVSRI Veterinary Vaccine Products Offered
7.25.5 RVSRI Recent Development
8 Veterinary Vaccine Manufacturing Cost Analysis
8.1 Veterinary Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Veterinary Vaccine
8.4 Veterinary Vaccine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Veterinary Vaccine Distributors List
9.3 Veterinary Vaccine Customers
10 Veterinary Vaccine Market Dynamics
10.1 Veterinary Vaccine Industry Trends
10.2 Veterinary Vaccine Market Drivers
10.3 Veterinary Vaccine Market Challenges
10.4 Veterinary Vaccine Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Veterinary Vaccine Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Veterinary Vaccine Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Veterinary Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Veterinary Vaccine Sales (M Doses) by Region (2020-2025)
Table 5. Global Veterinary Vaccine Sales Market Share by Region (2020-2025)
Table 6. Global Veterinary Vaccine Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Veterinary Vaccine Revenue Share by Region (2020-2025)
Table 8. Global Veterinary Vaccine Sales (M Doses) Forecast by Region (2026-2031)
Table 9. Global Veterinary Vaccine Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Veterinary Vaccine Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Veterinary Vaccine Revenue Share Forecast by Region (2026-2031)
Table 12. Global Veterinary Vaccine Sales by Type (M Doses) & (2020-2025)
Table 13. Global Veterinary Vaccine Sales Share by Type (2020-2025)
Table 14. Global Veterinary Vaccine Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Veterinary Vaccine Price by Type (USD/K Doses) & (2020-2025)
Table 16. Global Veterinary Vaccine Sales by Type (M Doses) & (2026-2031)
Table 17. Global Veterinary Vaccine Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Veterinary Vaccine Price by Type (USD/K Doses) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Veterinary Vaccine Sales by Application (M Doses) & (2020-2025)
Table 21. Global Veterinary Vaccine Sales Share by Application (2020-2025)
Table 22. Global Veterinary Vaccine Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Veterinary Vaccine Price by Application (USD/K Doses) & (2020-2025)
Table 24. Global Veterinary Vaccine Sales by Application (M Doses) & (2026-2031)
Table 25. Global Veterinary Vaccine Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Veterinary Vaccine Price by Application (USD/K Doses) & (2026-2031)
Table 27. New Sources of Growth in Veterinary Vaccine Application
Table 28. Global Veterinary Vaccine Sales by Company (M Doses) & (2020-2025)
Table 29. Global Veterinary Vaccine Sales Share by Company (2020-2025)
Table 30. Global Veterinary Vaccine Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Veterinary Vaccine Revenue Share by Company (2020-2025)
Table 32. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2024)
Table 33. Global Market Veterinary Vaccine Average Price by Company (USD/K Doses) & (2020-2025)
Table 34. Global Key Manufacturers of Veterinary Vaccine, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Veterinary Vaccine, Product Type & Application
Table 36. Global Key Manufacturers of Veterinary Vaccine, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Veterinary Vaccine Sales by Company (2020-2025) & (M Doses)
Table 39. North America Veterinary Vaccine Sales Market Share by Company (2020-2025)
Table 40. North America Veterinary Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Veterinary Vaccine Revenue Market Share by Company (2020-2025)
Table 42. North America Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 43. North America Veterinary Vaccine Sales Market Share by Type (2020-2025)
Table 44. North America Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 45. North America Veterinary Vaccine Sales Market Share by Application (2020-2025)
Table 46. Europe Veterinary Vaccine Sales by Company (2020-2025) & (M Doses)
Table 47. Europe Veterinary Vaccine Sales Market Share by Company (2020-2025)
Table 48. Europe Veterinary Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Veterinary Vaccine Revenue Market Share by Company (2020-2025)
Table 50. Europe Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 51. Europe Veterinary Vaccine Sales Market Share by Type (2020-2025)
Table 52. Europe Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 53. Europe Veterinary Vaccine Sales Market Share by Application (2020-2025)
Table 54. China Veterinary Vaccine Sales by Company (2020-2025) & (M Doses)
Table 55. China Veterinary Vaccine Sales Market Share by Company (2020-2025)
Table 56. China Veterinary Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Veterinary Vaccine Revenue Market Share by Company (2020-2025)
Table 58. China Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 59. China Veterinary Vaccine Sales Market Share by Type (2020-2025)
Table 60. China Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 61. China Veterinary Vaccine Sales Market Share by Application (2020-2025)
Table 62. Japan Veterinary Vaccine Sales by Company (2020-2025) & (M Doses)
Table 63. Japan Veterinary Vaccine Sales Market Share by Company (2020-2025)
Table 64. Japan Veterinary Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Veterinary Vaccine Revenue Market Share by Company (2020-2025)
Table 66. Japan Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 67. Japan Veterinary Vaccine Sales Market Share by Type (2020-2025)
Table 68. Japan Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 69. Japan Veterinary Vaccine Sales Market Share by Application (2020-2025)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 73. Merck Veterinary Vaccine Product
Table 74. Merck Recent Development
Table 75. Zoetis Company Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 78. Zoetis Veterinary Vaccine Product
Table 79. Zoetis Recent Development
Table 80. Boehringer Ingelheim Company Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 83. Boehringer Ingelheim Veterinary Vaccine Product
Table 84. Boehringer Ingelheim Recent Development
Table 85. Ceva Company Information
Table 86. Ceva Description and Business Overview
Table 87. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 88. Ceva Veterinary Vaccine Product
Table 89. Ceva Recent Development
Table 90. CAHIC Company Information
Table 91. CAHIC Description and Business Overview
Table 92. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 93. CAHIC Veterinary Vaccine Product
Table 94. CAHIC Recent Development
Table 95. HVRI Company Information
Table 96. HVRI Description and Business Overview
Table 97. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 98. HVRI Veterinary Vaccine Product
Table 99. HVRI Recent Development
Table 100. Ringpu Biology Company Information
Table 101. Ringpu Biology Description and Business Overview
Table 102. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 103. Ringpu Biology Veterinary Vaccine Product
Table 104. Ringpu Biology Recent Development
Table 105. Yebio Company Information
Table 106. Yebio Description and Business Overview
Table 107. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 108. Yebio Veterinary Vaccine Product
Table 109. Yebio Recent Development
Table 110. DHN Company Information
Table 111. DHN Description and Business Overview
Table 112. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 113. DHN Veterinary Vaccine Product
Table 114. DHN Recent Development
Table 115. WINSUN Company Information
Table 116. WINSUN Description and Business Overview
Table 117. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 118. WINSUN Veterinary Vaccine Product
Table 119. WINSUN Recent Development
Table 120. Elanco Company Information
Table 121. Elanco Description and Business Overview
Table 122. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 123. Elanco Veterinary Vaccine Product
Table 124. Elanco Recent Development
Table 125. Virbac Company Information
Table 126. Virbac Description and Business Overview
Table 127. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 128. Virbac Veterinary Vaccine Product
Table 129. Virbac Recent Development
Table 130. Jinyu Bio-Technology Company Information
Table 131. Jinyu Bio-Technology Description and Business Overview
Table 132. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 133. Jinyu Bio-Technology Veterinary Vaccine Product
Table 134. Jinyu Bio-Technology Recent Development
Table 135. Medion Company Information
Table 136. Medion Description and Business Overview
Table 137. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 138. Medion Veterinary Vaccine Product
Table 139. Medion Recent Development
Table 140. CAVAC Company Information
Table 141. CAVAC Description and Business Overview
Table 142. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 143. CAVAC Veterinary Vaccine Product
Table 144. CAVAC Recent Development
Table 145. Kyoto Biken Laboratories Company Information
Table 146. Kyoto Biken Laboratories Description and Business Overview
Table 147. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 148. Kyoto Biken Laboratories Veterinary Vaccine Product
Table 149. Kyoto Biken Laboratories Recent Development
Table 150. FATRO Company Information
Table 151. FATRO Description and Business Overview
Table 152. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 153. FATRO Veterinary Vaccine Product
Table 154. FATRO Recent Development
Table 155. Vaksindo Company Information
Table 156. Vaksindo Description and Business Overview
Table 157. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 158. Vaksindo Veterinary Vaccine Product
Table 159. Vaksindo Recent Development
Table 160. Bio-Labs Company Information
Table 161. Bio-Labs Description and Business Overview
Table 162. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 163. Bio-Labs Veterinary Vaccine Product
Table 164. Bio-Labs Recent Development
Table 165. Avimex Animal Health Company Information
Table 166. Avimex Animal Health Description and Business Overview
Table 167. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 168. Avimex Animal Health Veterinary Vaccine Product
Table 169. Avimex Animal Health Recent Development
Table 170. MEVAC Company Information
Table 171. MEVAC Description and Business Overview
Table 172. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 173. MEVAC Veterinary Vaccine Product
Table 174. MEVAC Recent Development
Table 175. Biovac Company Information
Table 176. Biovac Description and Business Overview
Table 177. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 178. Biovac Veterinary Vaccine Product
Table 179. Biovac Recent Development
Table 180. Atafen Company Information
Table 181. Atafen Description and Business Overview
Table 182. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 183. Atafen Veterinary Vaccine Product
Table 184. Atafen Recent Development
Table 185. Dyntec Company Information
Table 186. Dyntec Description and Business Overview
Table 187. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 188. Dyntec Veterinary Vaccine Product
Table 189. Dyntec Recent Development
Table 190. RVSRI Company Information
Table 191. RVSRI Description and Business Overview
Table 192. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 193. RVSRI Veterinary Vaccine Product
Table 194. RVSRI Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Veterinary Vaccine Distributors List
Table 198. Veterinary Vaccine Customers List
Table 199. Veterinary Vaccine Market Trends
Table 200. Veterinary Vaccine Market Drivers
Table 201. Veterinary Vaccine Market Challenges
Table 202. Veterinary Vaccine Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Vaccine Product Picture
Figure 2. Global Veterinary Vaccine Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Veterinary Vaccine Sales Market Share by Type in 2024 & 2031
Figure 4. Live Attenuated Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Other Product Picture
Figure 7. Global Veterinary Vaccine Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Veterinary Vaccine Sales Market Share by Application in 2024 & 2031
Figure 9. Farm Animal Examples
Figure 10. Companion Animal Examples
Figure 11. Global Veterinary Vaccine Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Veterinary Vaccine Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Veterinary Vaccine Sales (M Doses) Growth Rate (2020-2031)
Figure 14. Global Veterinary Vaccine Price Trends Growth Rate (2020-2031) & (USD/K Doses)
Figure 15. Veterinary Vaccine Report Years Considered
Figure 16. Global Market Veterinary Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Veterinary Vaccine Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Veterinary Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Veterinary Vaccine Sales (M Doses) Growth Rate (2020-2031)
Figure 20. Europe Veterinary Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Veterinary Vaccine Sales (M Doses) Growth Rate (2020-2031)
Figure 22. China Veterinary Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Veterinary Vaccine Sales (M Doses) Growth Rate (2020-2031)
Figure 24. Japan Veterinary Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Veterinary Vaccine Sales (M Doses) Growth Rate (2020-2031)
Figure 26. Global Veterinary Vaccine Revenue Share by Type (2020-2025)
Figure 27. Global Veterinary Vaccine Sales Share by Type (2026-2031)
Figure 28. Global Veterinary Vaccine Revenue Share by Type (2026-2031)
Figure 29. Global Veterinary Vaccine Revenue Share by Application (2020-2025)
Figure 30. Global Veterinary Vaccine Revenue Growth Rate by Application in 2020 & 2024
Figure 31. Global Veterinary Vaccine Sales Share by Application (2026-2031)
Figure 32. Global Veterinary Vaccine Revenue Share by Application (2026-2031)
Figure 33. Global Veterinary Vaccine Sales Share by Company (2024)
Figure 34. Global Veterinary Vaccine Revenue Share by Company (2024)
Figure 35. Global 5 Largest Veterinary Vaccine Players Market Share by Revenue in Veterinary Vaccine: 2020 & 2024
Figure 36. Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 37. Manufacturing Cost Structure of Veterinary Vaccine
Figure 38. Manufacturing Process Analysis of Veterinary Vaccine
Figure 39. Veterinary Vaccine Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
Table 1. Global Veterinary Vaccine Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Veterinary Vaccine Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Veterinary Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Veterinary Vaccine Sales (M Doses) by Region (2020-2025)
Table 5. Global Veterinary Vaccine Sales Market Share by Region (2020-2025)
Table 6. Global Veterinary Vaccine Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Veterinary Vaccine Revenue Share by Region (2020-2025)
Table 8. Global Veterinary Vaccine Sales (M Doses) Forecast by Region (2026-2031)
Table 9. Global Veterinary Vaccine Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Veterinary Vaccine Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Veterinary Vaccine Revenue Share Forecast by Region (2026-2031)
Table 12. Global Veterinary Vaccine Sales by Type (M Doses) & (2020-2025)
Table 13. Global Veterinary Vaccine Sales Share by Type (2020-2025)
Table 14. Global Veterinary Vaccine Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Veterinary Vaccine Price by Type (USD/K Doses) & (2020-2025)
Table 16. Global Veterinary Vaccine Sales by Type (M Doses) & (2026-2031)
Table 17. Global Veterinary Vaccine Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Veterinary Vaccine Price by Type (USD/K Doses) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Veterinary Vaccine Sales by Application (M Doses) & (2020-2025)
Table 21. Global Veterinary Vaccine Sales Share by Application (2020-2025)
Table 22. Global Veterinary Vaccine Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Veterinary Vaccine Price by Application (USD/K Doses) & (2020-2025)
Table 24. Global Veterinary Vaccine Sales by Application (M Doses) & (2026-2031)
Table 25. Global Veterinary Vaccine Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Veterinary Vaccine Price by Application (USD/K Doses) & (2026-2031)
Table 27. New Sources of Growth in Veterinary Vaccine Application
Table 28. Global Veterinary Vaccine Sales by Company (M Doses) & (2020-2025)
Table 29. Global Veterinary Vaccine Sales Share by Company (2020-2025)
Table 30. Global Veterinary Vaccine Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Veterinary Vaccine Revenue Share by Company (2020-2025)
Table 32. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2024)
Table 33. Global Market Veterinary Vaccine Average Price by Company (USD/K Doses) & (2020-2025)
Table 34. Global Key Manufacturers of Veterinary Vaccine, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Veterinary Vaccine, Product Type & Application
Table 36. Global Key Manufacturers of Veterinary Vaccine, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Veterinary Vaccine Sales by Company (2020-2025) & (M Doses)
Table 39. North America Veterinary Vaccine Sales Market Share by Company (2020-2025)
Table 40. North America Veterinary Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Veterinary Vaccine Revenue Market Share by Company (2020-2025)
Table 42. North America Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 43. North America Veterinary Vaccine Sales Market Share by Type (2020-2025)
Table 44. North America Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 45. North America Veterinary Vaccine Sales Market Share by Application (2020-2025)
Table 46. Europe Veterinary Vaccine Sales by Company (2020-2025) & (M Doses)
Table 47. Europe Veterinary Vaccine Sales Market Share by Company (2020-2025)
Table 48. Europe Veterinary Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Veterinary Vaccine Revenue Market Share by Company (2020-2025)
Table 50. Europe Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 51. Europe Veterinary Vaccine Sales Market Share by Type (2020-2025)
Table 52. Europe Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 53. Europe Veterinary Vaccine Sales Market Share by Application (2020-2025)
Table 54. China Veterinary Vaccine Sales by Company (2020-2025) & (M Doses)
Table 55. China Veterinary Vaccine Sales Market Share by Company (2020-2025)
Table 56. China Veterinary Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Veterinary Vaccine Revenue Market Share by Company (2020-2025)
Table 58. China Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 59. China Veterinary Vaccine Sales Market Share by Type (2020-2025)
Table 60. China Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 61. China Veterinary Vaccine Sales Market Share by Application (2020-2025)
Table 62. Japan Veterinary Vaccine Sales by Company (2020-2025) & (M Doses)
Table 63. Japan Veterinary Vaccine Sales Market Share by Company (2020-2025)
Table 64. Japan Veterinary Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Veterinary Vaccine Revenue Market Share by Company (2020-2025)
Table 66. Japan Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 67. Japan Veterinary Vaccine Sales Market Share by Type (2020-2025)
Table 68. Japan Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 69. Japan Veterinary Vaccine Sales Market Share by Application (2020-2025)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 73. Merck Veterinary Vaccine Product
Table 74. Merck Recent Development
Table 75. Zoetis Company Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 78. Zoetis Veterinary Vaccine Product
Table 79. Zoetis Recent Development
Table 80. Boehringer Ingelheim Company Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 83. Boehringer Ingelheim Veterinary Vaccine Product
Table 84. Boehringer Ingelheim Recent Development
Table 85. Ceva Company Information
Table 86. Ceva Description and Business Overview
Table 87. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 88. Ceva Veterinary Vaccine Product
Table 89. Ceva Recent Development
Table 90. CAHIC Company Information
Table 91. CAHIC Description and Business Overview
Table 92. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 93. CAHIC Veterinary Vaccine Product
Table 94. CAHIC Recent Development
Table 95. HVRI Company Information
Table 96. HVRI Description and Business Overview
Table 97. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 98. HVRI Veterinary Vaccine Product
Table 99. HVRI Recent Development
Table 100. Ringpu Biology Company Information
Table 101. Ringpu Biology Description and Business Overview
Table 102. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 103. Ringpu Biology Veterinary Vaccine Product
Table 104. Ringpu Biology Recent Development
Table 105. Yebio Company Information
Table 106. Yebio Description and Business Overview
Table 107. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 108. Yebio Veterinary Vaccine Product
Table 109. Yebio Recent Development
Table 110. DHN Company Information
Table 111. DHN Description and Business Overview
Table 112. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 113. DHN Veterinary Vaccine Product
Table 114. DHN Recent Development
Table 115. WINSUN Company Information
Table 116. WINSUN Description and Business Overview
Table 117. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 118. WINSUN Veterinary Vaccine Product
Table 119. WINSUN Recent Development
Table 120. Elanco Company Information
Table 121. Elanco Description and Business Overview
Table 122. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 123. Elanco Veterinary Vaccine Product
Table 124. Elanco Recent Development
Table 125. Virbac Company Information
Table 126. Virbac Description and Business Overview
Table 127. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 128. Virbac Veterinary Vaccine Product
Table 129. Virbac Recent Development
Table 130. Jinyu Bio-Technology Company Information
Table 131. Jinyu Bio-Technology Description and Business Overview
Table 132. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 133. Jinyu Bio-Technology Veterinary Vaccine Product
Table 134. Jinyu Bio-Technology Recent Development
Table 135. Medion Company Information
Table 136. Medion Description and Business Overview
Table 137. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 138. Medion Veterinary Vaccine Product
Table 139. Medion Recent Development
Table 140. CAVAC Company Information
Table 141. CAVAC Description and Business Overview
Table 142. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 143. CAVAC Veterinary Vaccine Product
Table 144. CAVAC Recent Development
Table 145. Kyoto Biken Laboratories Company Information
Table 146. Kyoto Biken Laboratories Description and Business Overview
Table 147. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 148. Kyoto Biken Laboratories Veterinary Vaccine Product
Table 149. Kyoto Biken Laboratories Recent Development
Table 150. FATRO Company Information
Table 151. FATRO Description and Business Overview
Table 152. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 153. FATRO Veterinary Vaccine Product
Table 154. FATRO Recent Development
Table 155. Vaksindo Company Information
Table 156. Vaksindo Description and Business Overview
Table 157. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 158. Vaksindo Veterinary Vaccine Product
Table 159. Vaksindo Recent Development
Table 160. Bio-Labs Company Information
Table 161. Bio-Labs Description and Business Overview
Table 162. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 163. Bio-Labs Veterinary Vaccine Product
Table 164. Bio-Labs Recent Development
Table 165. Avimex Animal Health Company Information
Table 166. Avimex Animal Health Description and Business Overview
Table 167. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 168. Avimex Animal Health Veterinary Vaccine Product
Table 169. Avimex Animal Health Recent Development
Table 170. MEVAC Company Information
Table 171. MEVAC Description and Business Overview
Table 172. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 173. MEVAC Veterinary Vaccine Product
Table 174. MEVAC Recent Development
Table 175. Biovac Company Information
Table 176. Biovac Description and Business Overview
Table 177. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 178. Biovac Veterinary Vaccine Product
Table 179. Biovac Recent Development
Table 180. Atafen Company Information
Table 181. Atafen Description and Business Overview
Table 182. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 183. Atafen Veterinary Vaccine Product
Table 184. Atafen Recent Development
Table 185. Dyntec Company Information
Table 186. Dyntec Description and Business Overview
Table 187. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 188. Dyntec Veterinary Vaccine Product
Table 189. Dyntec Recent Development
Table 190. RVSRI Company Information
Table 191. RVSRI Description and Business Overview
Table 192. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 193. RVSRI Veterinary Vaccine Product
Table 194. RVSRI Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Veterinary Vaccine Distributors List
Table 198. Veterinary Vaccine Customers List
Table 199. Veterinary Vaccine Market Trends
Table 200. Veterinary Vaccine Market Drivers
Table 201. Veterinary Vaccine Market Challenges
Table 202. Veterinary Vaccine Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Vaccine Product Picture
Figure 2. Global Veterinary Vaccine Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Veterinary Vaccine Sales Market Share by Type in 2024 & 2031
Figure 4. Live Attenuated Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Other Product Picture
Figure 7. Global Veterinary Vaccine Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Veterinary Vaccine Sales Market Share by Application in 2024 & 2031
Figure 9. Farm Animal Examples
Figure 10. Companion Animal Examples
Figure 11. Global Veterinary Vaccine Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Veterinary Vaccine Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Veterinary Vaccine Sales (M Doses) Growth Rate (2020-2031)
Figure 14. Global Veterinary Vaccine Price Trends Growth Rate (2020-2031) & (USD/K Doses)
Figure 15. Veterinary Vaccine Report Years Considered
Figure 16. Global Market Veterinary Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Veterinary Vaccine Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Veterinary Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Veterinary Vaccine Sales (M Doses) Growth Rate (2020-2031)
Figure 20. Europe Veterinary Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Veterinary Vaccine Sales (M Doses) Growth Rate (2020-2031)
Figure 22. China Veterinary Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Veterinary Vaccine Sales (M Doses) Growth Rate (2020-2031)
Figure 24. Japan Veterinary Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Veterinary Vaccine Sales (M Doses) Growth Rate (2020-2031)
Figure 26. Global Veterinary Vaccine Revenue Share by Type (2020-2025)
Figure 27. Global Veterinary Vaccine Sales Share by Type (2026-2031)
Figure 28. Global Veterinary Vaccine Revenue Share by Type (2026-2031)
Figure 29. Global Veterinary Vaccine Revenue Share by Application (2020-2025)
Figure 30. Global Veterinary Vaccine Revenue Growth Rate by Application in 2020 & 2024
Figure 31. Global Veterinary Vaccine Sales Share by Application (2026-2031)
Figure 32. Global Veterinary Vaccine Revenue Share by Application (2026-2031)
Figure 33. Global Veterinary Vaccine Sales Share by Company (2024)
Figure 34. Global Veterinary Vaccine Revenue Share by Company (2024)
Figure 35. Global 5 Largest Veterinary Vaccine Players Market Share by Revenue in Veterinary Vaccine: 2020 & 2024
Figure 36. Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 37. Manufacturing Cost Structure of Veterinary Vaccine
Figure 38. Manufacturing Process Analysis of Veterinary Vaccine
Figure 39. Veterinary Vaccine Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232